Cartalax
Cartalax is a synthetic tripeptide (Ala–Glu–Asp) classified within the Khavinson peptide bioregulator system. It has been studied primarily in preclinical laboratory settings, including in vitro and animal models, where research from its originating group reports effects on chondrocyte gene expression and cartilage-related cellular markers. These findings remain unconfirmed by independent research and have not been validated in large-scale human clinical trials.
Cartalax
Sale!3%
Cartalax is a synthetic tripeptide (Ala–Glu–Asp) classified within the Khavinson peptide bioregulator system. It has been studied primarily in preclinical laboratory settings, including in vitro and animal models, where research from its originating group reports effects on chondrocyte gene expression and cartilage-related cellular markers. These findings remain unconfirmed by independent research and have not been validated in large-scale human clinical trials.
$167.00
Buy more, save more!
-
Save 1%
Buy 3, get $2.50 off each
$167.00Per item: $164.50Total price: $493.50 -
Save 2%
Buy 5, get $3.75 off each
$167.00Per item: $163.25Total price: $816.25 -
Save 4%
Buy 10, get $7.50 off each
$167.00Per item: $159.50Total price: $1,595.00
$173.00$167.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
Cartalax (Ala–Glu–Asp, AED) is a synthetic tripeptide that has been studied in limited preclinical research, primarily in cell culture and animal models associated with peptide bioregulator research programs. Preclinical experiments report that AED may influence cellular activity in models involving connective tissue, including chondrocyte and fibroblast systems, with observed changes in general markers related to cell proliferation, stress response, and extracellular matrix regulation under laboratory conditions.
Additional experimental work has investigated AED in kidney, stem cell, and cartilage-related models, where researchers have reported changes in cellular activity and gene expression markers under controlled conditions.
However, the exact molecular mechanisms of action are not fully established, and no confirmed receptor targets, signalling pathways, or clinically validated biological effects have been demonstrated.
| Strength Variation |
|---|
There are no reviews yet.